Latest filing published 15 Nov 2017 for Supreme Pharmaceuticals Inc..
John Alexander Fowler is a declared insider of Supreme Pharmaceuticals Inc., with filings sourced from SEDI. The record holds 11 filings, for trades running from 2 June 2014 to 17 October 2017.
In open-market terms, that means 4 purchases worth €39k on one side and 4 sales worth €66k on the other. Netting one side against the other leaves €27k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2017 alone, the filings show 2 purchases and 1 sale.
The median purchase comes to €9,003. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 15 November 2017, reports an open-market sale of €36k in Supreme Pharmaceuticals Inc. The last purchase on record was published on 17 July 2017, which is 3,386 days ago. Filings reach the SEDI feed a median of 3 days after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations